ATPG3: Medication and supplements
Year | ≥ 2011 | ≥ 2011 | ≥ 2011 | ≥ 2011 | ≥ 2015 | ≥ 2017 | 2020
*During COVID-19 |
---|---|---|---|---|---|---|---|
Wave | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
Age | 32 weeks gestation | birth | 8 weeks | 12 months | 4 years | 6 years | 9 years |
Medication during pregnancy | P:SDV | X (TBD) | X (TBD) | ||||
Medications (sleeping aids/sedatives) | X (TBD) | X (TBD) | P:CRISIS |
Featured measurements
CRISIS: CoRonavIruS Health Impact Survey (various instruments)SDV: Study Devised Variable
Legend
A | = Administration report abstraction |
C | = Index child report (reporting on others) |
L | = Linkage (to other databases) |
M | = Medical records data abstraction |
O | = Observation/direct assessment |
N | = Nurse report |
P | = Parent/primary caregiver report |
Pe | = Peer report |
S | = Self report |
T | = Teacher report |
X | = Undefined |
X BF | = Pertaining to biological father |
X BM | = Pertaining to biological mother |
X C | = Pertaining to index child |
X F | = Pertaining to father |
X Fam | = Pertaining to family |
X G | = Pertaining to grandparent(s) |
X M | = Pertaining to mother |
X P | = Pertaining to parent(s) |
X Pa | = Pertaining to partner |
X Pe | = Pertaining to peers |
X Pr | = Pertaining to primary caregiver |
X Si | = Pertaining to sibling(s) |